熱門資訊> 正文
AEON、SGGX和APVO均为上市前输家
2024-05-03 20:36
- Losers: AEON Biopharma (AEON) -46% announces preliminary top-line results from phase 2 interim analysis of ABP-450 in the preventive treatment of chronic migraine.
- Sprout Social (SPT) -29% after Q1 earnings release.
- Marin Software (MRIN) -19% after Q1 earnings release.
- Stem (STEM) -19% shows Q1 results.
- Terran Orbital Corp (LLAP) -17% as Lockheed Martin withdraws takeover offer.
- Cloudflare (NET) -14% after Q1 earnings release.
- BigBear.ai Holdings (BBAI) -12% after Q1 earnings release.
- Expedia Group (EXPE) -11% after Q1 earnings release.
- Cardiff Oncology (CRDF) -11% after Q1 earnings release.
- Aptevo Therapeutics (APVO) -12%.
- Context Therapeutics (CNTX) -9%.
- Fortinet (FTNT) -8% beats Q1 estimates.
- Safe & Green Holdings Corp (SGBX) -7%.
- LQR House (LQR) -6%.
More on pre-market losers & stocks.
- Safe & Green signs deal for design and production of eight units, currently in concept stage
- Seeking Alpha’s Quant Rating on AEON Biopharma, Inc.
- Historical earnings data for AEON Biopharma, Inc.
- Financial information for AEON Biopharma, Inc.
- Seeking Alpha’s Quant Rating on Aptevo Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
